Related references
Note: Only part of the references are listed.Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study
Long-Bin Jeng et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
OPTN/SRTR 2016 Annual Data Report: Liver
W. R. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Manuel Rodriguez-Peralvarez et al.
TRANSPLANTATION (2018)
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients
T. M. Manzia et al.
TRANSPLANTATION PROCEEDINGS (2018)
Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma
Sam Grigg et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Effects of Maintenance Immunosuppression With Sirolimus After Liver Transplant for Hepatocellular Carcinoma
Elizabeth L. Yanik et al.
LIVER TRANSPLANTATION (2016)
Liver transplantation in the United Kingdom
James Neuberger
LIVER TRANSPLANTATION (2016)
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Edward K. Geissler et al.
TRANSPLANTATION (2016)
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review
Dong-Wei Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma
Shi-lei Xu et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation
Chuan Shen et al.
ONCOTARGET (2016)
n Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
Hallvard Holdaas et al.
JOURNAL OF TRANSPLANTATION (2016)
Everolimus and sirolimus in transplantation-related but different
Jost Klawitter et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study
Lutz Fischer et al.
TRANSPLANTATION (2015)
Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
Nicola de'Angelis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?
Christophe Duvoux et al.
TRANSPLANTATION REVIEWS (2015)
Review article: liver transplantation for hepatocellular carcinoma - a critical appraisal of the current worldwide listing criteria
K. V. Menon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Waiting Time and Explant Pathology in Transplant Recipients With Hepatocellular Carcinoma: A Novel Study Using National Data
T. Bittermann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
De Novo Sirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000-2003 Phase II Prospective Randomized Trial
S. K. Asrani et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience
Evangelos Cholongitas et al.
HEPATOLOGY INTERNATIONAL (2014)
Everolimus-Based Immunosuppression in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Liver Transplantation: A Case Series
A. O. Ferreiro et al.
TRANSPLANTATION PROCEEDINGS (2014)
The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
Goran B. Klintmalm et al.
JOURNAL OF TRANSPLANTATION (2014)
Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
K. V. Menon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
EVEROLIMUS IN LIVER TRANSPLANTATION TO PREVENT HEPATOCELLULAR CARCINOMA RECURRENCE IN THE PRESENCE OF EXTENDED MILAN CRITERIA
P. Houssel et al.
JOURNAL OF HEPATOLOGY (2013)
Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma
Manuel Rodriguez-Peralvarez et al.
JOURNAL OF HEPATOLOGY (2013)
Calcineurin Inhibitor-Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial
Lewis Teperman et al.
LIVER TRANSPLANTATION (2013)
Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge
Martin-Walter Welker et al.
TRANSPLANT INTERNATIONAL (2013)
Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma
J. R. L. Maggs et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
Wenhua Liang et al.
LIVER TRANSPLANTATION (2012)
Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
M. Masetti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma
Marco Vivarelli et al.
TRANSPLANTATION (2010)
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Impact of Sirolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Srinath Chinnakotla et al.
LIVER TRANSPLANTATION (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Recurrence of hepatocellular carcinoma following liver transplantation - A review of preoperative and postoperative prognostic indicators
Michael A. Zimmerman et al.
ARCHIVES OF SURGERY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
Michael A. Zimmerman et al.
LIVER TRANSPLANTATION (2008)
Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria
J. Zhou et al.
TRANSPLANTATION PROCEEDINGS (2008)
Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles
Ian Shrier et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma
David Semela et al.
JOURNAL OF HEPATOLOGY (2007)
The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey
John P. A. Ioannidis et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
